Basilea Pharmaceutica AG Stock Xetra
Stocks
PK5
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
12:17:19 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 72.15 EUR | 0.00% |
|
0.00% | - |
| 09-14 | Japanese Stocks Fall on AI Development Slowdown Calls; Oil Gains | MT |
| 09-14 | Asahi Kasei Unit Starts Phase Two Study of Antifungal Cresemba for Pediatric Patients in Japan | MT |
| Market Cap | 842M 1.01B 900M 767M 1.44B 97.59B 1.46B 10.19B 3.94B 49.7B 3.81B 3.72B 160B | P/E 2026 * |
15.7x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 689M 830M 737M 628M 1.18B 79.89B 1.2B 8.34B 3.23B 40.69B 3.12B 3.05B 131B | EV / Sales 2026 * |
2.57x | EV / Sales 2027 * | 2.27x |
| Free-Float |
91.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 1.01B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -0.86% | -1.33% | +24.70% | +78.59% | 59.26B | |
| +1.03% | -0.39% | +4.54% | +34.84% | 47.14B | |
| -3.02% | -5.20% | +27.94% | +32.51% | 42.91B | |
| +0.31% | +3.02% | +348.95% | +643.82% | 44.13B | |
| -1.96% | -0.33% | +7.04% | +99.46% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +330.06% | 23.71B | |
| Average | -0.45% | -0.52% | +52.89% | +154.16% | 43.6B | |
| Weighted average by Cap. | +0.06% | -0.32% | +58.08% | +145.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 268M 323M 287M 244M 460M 31.06B 466M 3.24B 1.25B 15.82B 1.21B 1.18B 50.8B | 275M 331M 294M 251M 472M 31.9B 479M 3.33B 1.29B 16.24B 1.24B 1.22B 52.18B |
| Net income | 68.7M 82.71M 73.46M 62.6M 118M 7.96B 119M 831M 322M 4.06B 311M 304M 13.03B | 58.3M 70.19M 62.34M 53.13M 100M 6.76B 101M 705M 273M 3.44B 264M 258M 11.05B |
| Net Debt | -153M -184M -163M -139M -262M -17.7B -266M -1.85B -715M -9.01B -690M -675M -28.95B | -218M -262M -233M -199M -374M -25.26B -379M -2.64B -1.02B -12.86B -985M -964M -41.31B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BSLN Stock
- PK5 Stock
Select your edition
All financial news and data tailored to specific country editions
